ORLY:NASDAQO'Reilly Automotive, Inc. Analysis
Data as of 2026-05-26 - not real-time
$89.87
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
O'Reilly Automotive posted a robust 10.2% revenue increase and an 8.1% comparable store sales lift in Q1 2026, underscoring its resilient demand drivers and solid operating margins of 18.5% (gross margin 51.6%). Analysts remain bullish, with a median 12‑month price target of $110, implying roughly 22% upside from the current $89.87 price. However, the stock trades below its 20‑day ($92.58) and 50‑day ($92.06) moving averages, the MACD has turned bearish, and the RSI sits at a neutral 42, suggesting short‑term price pressure. Volatility is elevated at 30% over the past month, though beta is modest at 0.18, indicating limited systematic risk. The DCF model values the company at roughly $22 per share, far below market levels, and a PE of 29x signals a premium valuation.
Given the strong fundamentals, positive earnings momentum, and analyst optimism, the medium‑ to long‑term outlook remains favorable, but investors should be cautious of near‑term technical weakness and the high valuation premium.
Given the strong fundamentals, positive earnings momentum, and analyst optimism, the medium‑ to long‑term outlook remains favorable, but investors should be cautious of near‑term technical weakness and the high valuation premium.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and price below short‑term moving averages
- Elevated 30% 30‑day volatility
- Support level near $86.8 providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 10.2% YoY revenue growth and 8.1% comparable store sales expansion
- Analyst consensus of "Buy" with median target $110
- Strong operating margins and cash flow generation
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Durable consumer‑cyclical business model with expanding footprint
- Low beta indicating limited market‑wide risk exposure
- Consistent profitability and ability to compound earnings over decades
Key Metrics & Analysis
Financial Health
Revenue Growth10.20%
Profit Margin14.30%
P/E Ratio29.3
ROA13.81%
P/B Ratio-70.1
Op. Cash Flow$3.0B
Free Cash Flow$1.3B
Technical Analysis
TrendNeutral
RSI42.3
Support$86.80
Resistance$100.63
MA 20$92.58
MA 50$92.06
MA 200$96.78
MACDBearish
VolumeStable
Fear & Greed Index91.05
Valuation
Fair Value$21.94
Target Price$109.70
Upside/Downside22.06%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.18
Volatility32.25%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.